Bank Of America Corp I Bio, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $160.0 $123 - $86,080	-538 Reduced 99.26%	4 $0
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.46 $8,216 - $16,433	-35,725 Reduced 98.51%	542 $0
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $24,297 - $49,403	-80,990 Reduced 69.07%	36,267 $16,000
Q4 2021 Feb 08, 2022	BUY	$0.55 - $1.04 $15,722 - $29,729	28,586 Added 32.24%	117,257 $65,000
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $23,809 - $34,142	22,462 Added 33.93%	88,671 $94,000
Q2 2021 Sep 13, 2021	BUY	$1.22 - $1.65 $80,774 - $109,244	66,209 New	66,209 $100,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.